These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Hemodialysis vascular access dysfunction: from pathophysiology to novel therapies. Roy-Chaudhury P; Kelly BS; Zhang J; Narayana A; Desai P; Melham M; Duncan H; Heffelfinger SC Blood Purif; 2003; 21(1):99-110. PubMed ID: 12596755 [TBL] [Abstract][Full Text] [Related]
65. Perivascular medical devices and drug delivery systems: Making the right choices. Mylonaki I; Allémann É; Saucy F; Haefliger JA; Delie F; Jordan O Biomaterials; 2017 Jun; 128():56-68. PubMed ID: 28288349 [TBL] [Abstract][Full Text] [Related]
66. Development of a local perivascular paclitaxel delivery system for hemodialysis vascular access dysfunction: polymer preparation and in vitro activity. Melhem M; Kelly B; Zhang J; Kasting G; Li J; Davis H; Heffelfinger S; Desai P; Roy-Chaudhury P Blood Purif; 2006; 24(3):289-98. PubMed ID: 16465049 [TBL] [Abstract][Full Text] [Related]
67. Novel therapies for hemodialysis vascular access dysfunction: fact or fiction! Roy-Chaudhury P; Kelly BS; Melhem M; Zhang J; Li J; Desai P; Munda R; Heffelfinger SC Blood Purif; 2005; 23(1):29-35. PubMed ID: 15627734 [TBL] [Abstract][Full Text] [Related]
68. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. Roy-Chaudhury P; Sukhatme VP; Cheung AK J Am Soc Nephrol; 2006 Apr; 17(4):1112-27. PubMed ID: 16565259 [TBL] [Abstract][Full Text] [Related]